Nearly 44% of primary care visits for Medicare fee-for-service beneficiaries were telehealth visits in April, up from 0.1% in February, according to a report released this week by the Department of Health and Human Services.

Medicare fee-for-service telehealth visits for primary care climbed from about 14,000 per week before the COVID-19 pandemic to 1.3 million per week in April, HHS said.

The Centers for Medicare & Medicaid Services has waived Medicare geographic and originating site restrictions on telehealth and expanded the list of telehealth-eligible services and practitioners during the emergency.

HHS Secretary Alex Azar said the report “shows that Medicare providers and beneficiaries rapidly embraced these new opportunities. The meteoric rise of telehealth during the pandemic has not only helped us combat the virus, but also prompted a new conversation around the future of patient-centered care."

AHA has urged Congress and the Administration to ensure flexibilities remain in place after the public health emergency, as well as to reimburse virtual services on par with in-person care. For more information, see the new AHA factsheet on the future of telehealth.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services released a memo Dec. 16 announcing the agency’s intent to conduct a voluntary pilot in 2026, called the…
Headline
The Centers for Medicare & Medicaid Services Dec. 15 published the Measures Under Consideration List for 2025. These are measures that CMS is considering…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The Medicare Payment Advisory Commission Dec. 4 and 5 discussed draft payment update recommendations for 2027, which the commission will vote on in January.…
Headline
The House Dec. 1 passed the Hospital Inpatient Services Modernization Act (H.R. 4313), legislation extending certain Medicare waivers authorizing the hospital-…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…